Vivanza Biosciences Limited (BOM:530057)
1.770
0.00 (0.00%)
At close: May 26, 2026
Vivanza Biosciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 0.65 | 1.17 | 1.67 | 1.41 | 0.55 |
Short-Term Investments | - | 0.3 | 0.29 | 0.29 | 0.01 |
Cash & Short-Term Investments | 0.65 | 1.47 | 1.96 | 1.7 | 0.56 |
Cash Growth | -55.52% | -25.03% | 15.11% | 203.21% | - |
Accounts Receivable | 123.83 | 80.59 | 115.39 | 124.79 | 78.4 |
Receivables | 150.93 | 97.03 | 131.62 | 166.11 | 97.69 |
Inventory | 35.51 | 22.63 | 20.06 | 24.75 | 24.28 |
Other Current Assets | 3.46 | 2.72 | 3.77 | 2.98 | 1.98 |
Total Current Assets | 190.55 | 123.84 | 157.41 | 195.54 | 124.51 |
Property, Plant & Equipment | 8.01 | 6.99 | 7.05 | 6.8 | 6.82 |
Long-Term Investments | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
Goodwill | - | 16.05 | 16.05 | 16.05 | 16.05 |
Other Intangible Assets | 16.35 | 0.3 | 0.3 | 0.3 | 0.3 |
Long-Term Deferred Tax Assets | - | 0.01 | 0.02 | 0.01 | 0.01 |
Other Long-Term Assets | 5.93 | 5.93 | 5.93 | 5.93 | 5.93 |
Total Assets | 220.87 | 164.53 | 195.01 | 224.77 | 155.62 |
Accounts Payable | 71.94 | 26.18 | 82.35 | 95.49 | 54.85 |
Accrued Expenses | 1.61 | 0.37 | 0.22 | 0.25 | 0.22 |
Short-Term Debt | - | 18.74 | 22.07 | 32.77 | 27.36 |
Current Portion of Long-Term Debt | 93.15 | 34.44 | 2.81 | 32.87 | 1.75 |
Current Income Taxes Payable | - | 0.23 | 2.67 | 1.43 | 0.25 |
Current Unearned Revenue | - | 5.42 | 4.19 | 6.6 | 3.98 |
Other Current Liabilities | 1.82 | 6.17 | 7.52 | 0.13 | 6.32 |
Total Current Liabilities | 168.52 | 91.54 | 121.81 | 169.53 | 94.73 |
Long-Term Debt | 8.77 | 33.35 | 26.82 | 14.33 | 25.97 |
Long-Term Deferred Tax Liabilities | 0 | - | - | - | - |
Other Long-Term Liabilities | - | 0 | 0 | - | - |
Total Liabilities | 177.29 | 124.89 | 148.63 | 183.86 | 120.69 |
Common Stock | 40 | 40 | 40 | 40 | 40 |
Retained Earnings | 3.59 | -0.36 | 6.38 | 0.91 | -5.08 |
Shareholders' Equity | 43.59 | 39.64 | 46.38 | 40.91 | 34.93 |
Total Liabilities & Equity | 220.87 | 164.53 | 195.01 | 224.77 | 155.62 |
Total Debt | 101.92 | 86.52 | 51.7 | 79.97 | 55.08 |
Net Cash (Debt) | -101.27 | -85.05 | -49.74 | -78.27 | -54.52 |
Net Cash Per Share | -2.57 | -2.13 | -1.27 | -1.96 | -1.36 |
Filing Date Shares Outstanding | 37.02 | 40 | 40 | 40 | 40 |
Total Common Shares Outstanding | 37.02 | 40 | 40 | 40 | 40 |
Working Capital | 22.03 | 32.3 | 35.6 | 26.01 | 29.78 |
Book Value Per Share | 1.18 | 0.99 | 1.16 | 1.02 | 0.87 |
Tangible Book Value | 27.23 | 23.29 | 30.03 | 24.56 | 18.57 |
Tangible Book Value Per Share | 0.74 | 0.58 | 0.75 | 0.61 | 0.46 |
Land | - | 1.42 | 1.42 | 1.42 | 1.42 |
Buildings | - | 2.46 | 2.46 | 2.46 | 2.46 |
Machinery | - | 5.37 | 5.29 | 4.92 | 4.92 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.